| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |